by 
The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Automated cell counters are laboratory instruments used to count and analyze the cells present in a liquid suspension. These counters provide accurate and rapid cell counting compared to manual methods. Automated cell counters are used in various applications such as biological sample analysis, disease diagnosis, and drug discovery. Increasing prevalence of chronic diseases has boosted cell-based research, thereby driving the demand for automated cell counters.
Market key trends:
One of the major trends in the automated cell counters market is the development of advanced cell imaging and analysis solutions. Key players are focusing on developing innovative cell counters integrated with microscopy, flow cytometry, and image analysis capabilities. For instance, Nexcelom’s Auto T4+ Cell Counter provides automated total and differential cell counting along with cell morphology assessment through integrated high-resolution image capture and analysis. Such advanced cell counters help researchers gain comprehensive insights by combining cell quantification with qualitative analysis of cell structures and properties.
Porter’s Analysis
Threat of new entrants: The market requires high initial capital investment in R&D and production which poses low threat of new entrants.
Bargaining power of buyers: The presence of several market players provides buyers with variety and competitive prices reducing their bargaining power.
Bargaining power of suppliers: The key components are available from multiple global suppliers reducing the individual suppliers’ bargaining power.
Threat of new substitutes: There exist no close substitutes for automated cell counters and substitutes require high switching costs posing low threat of new substitutes.
Competitive rivalry: The market is dominated by few global players intensifying competition on the basis of product innovation, quality, and pricing.
Key Takeaways
The global Automated Cell Counters market is expected to witness high growth, exhibiting CAGR of 7.0% over the forecast period, due to increasing prevalence of chronic and infectious diseases.
The global market size for Automated Cell Counters reached US$ 3.75 Bn in 2023. Regional analysis
North America dominated the global market in 2023, owing to rising healthcare expenditure and advanced healthcare infrastructure in the region. Asia Pacific is anticipated to be the fastest growing market between 2023 to 2030 attributed to growing geriatric population, increasing healthcare spending, and rising awareness.
Key players operating in the Automated Cell Counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan. Thermo Fisher Scientific and Danaher Corporation collectively accounted for over 30% of the global market share in 2023.
